Ichnos Glenmark Hires Mariana Cota Stirner as CMO
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Ichnos Glenmark Innovation hired Mariana Cota Stirner as chief medical officer, the featured move in STAT's regular "up and down the ladder" column.
- Mariana Cota Stirner most recently served as fractional chief medical officer and head of clinical development at Azalea Therapeutics.
- Stirner previously held the role of vice president and therapeutic area head of hematology at AbbVie.
- STAT's column runs as a weekly feature highlighting a single personnel move, with the outlet inviting industry insiders to submit their own comings and goings.
Why it matters: For Ichnos Glenmark Innovation, naming a permanent CMO with senior hematology experience from AbbVie and prior clinical-development leadership at Azalea Therapeutics signals the company is building out its clinical organization as it advances its pipeline.
